Literature DB >> 8621220

The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC).

H F Vasen1, E A Sanders, B G Taal, F M Nagengast, G Griffioen, F H Menko, J H Kleibeuker, J J Houwing-Duistermaat, P Meera Khan.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is known to be associated with several extracolonic cancers, e.g., cancers of the endometrium, stomach, urinary tract, small bowel and ovary. An association between HNPCC and brain tumours has also been reported, although previous risk analysis did not reveal an excess of this type of tumour. To determine whether HNPCC predisposes patients to brain tumours, we used risk analysis to compare families with HNPCC to those in the general population. Of the 1,321 subjects from 50 HNPCC families (with 60,237 person-years of follow-up) in the Dutch HNPCC Registry which satisfy the Amsterdam Criteria, 312 had colorectal cancer. The registry revealed 14 brain tumours in the HNPCC-patients and their first-degree relatives: 5 astrocytomas, 3 oligodendrogliomas, 1 ependymoma and 5 tumours for which a pathological report was not available. The relative risk of brain tumour in patients with HNPCC and their first-degree relatives was 6 times greater than in the general population (95% confidence interval, 3.5 to 10.1). After exclusion of the cases based only on family history, the relative risk was 4.3 (95% confidence interval, 2.3 to 8.0). Although the relative risk of brain tumour was increased, the lifetime risk was low (3.35%). Because it is not certain whether an improvement of the overall prognosis can be achieved by early diagnosis and intervention, and in view of the low lifetime risk, we do not recommend screening for brain tumours in HNPCC families.

Entities:  

Mesh:

Year:  1996        PMID: 8621220     DOI: 10.1002/(SICI)1097-0215(19960208)65:4<422::AID-IJC4>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Survival of patients with ovarian cancer due to a mismatch repair defect.

Authors:  Th E M Crijnen; M L G Janssen-Heijnen; H Gelderblom; J Morreau; M A Nooij; G G Kenter; H F A Vasen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 2.  Surveillance in Lynch syndrome.

Authors:  Jukka-Pekka Mecklin; Heikki J Järvinen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 3.  Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].

Authors:  H F A Vasen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population.

Authors:  Yuan-Zhi Zhang; Jian-Qiu Sheng; Shi-Rong Li; Hong Zhang
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

5.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

Review 6.  Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.

Authors:  Kristen M Drescher; Poonam Sharma; Henry T Lynch
Journal:  Clin Dev Immunol       Date:  2010-06-10

7.  Anaplastic oligoastrocytoma in Turcot syndrome.

Authors:  Joachim Baehring; Pei Hui; Joseph Piepmeier; Serguei I Bannykh
Journal:  J Neurooncol       Date:  2009-06-04       Impact factor: 4.130

8.  The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study.

Authors:  W Müller; L J Burgart; R Krause-Paulus; S N Thibodeau; M Almeida; T B Edmonston; C R Boland; C Sutter; J R Jass; A Lindblom; J Lubinski; K MacDermot; D S Sanders; H Morreau; A Müller; C Oliani; T Orntoft; M Ponz De Leon; C Rosty; M Rodriguez-Bigas; J Rüschoff; A Ruszkiewicz; J Sabourin; R Salovaara; G Möslein
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

9.  Genetic detection of Chinese hereditary nonpolyposis colorectal cancer.

Authors:  Long Cui; Hei-Ying Jin; Hui-Yu Cheng; Yu-Di Yan; Rong-Gui Meng; De-Hong Yu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

10.  Microsatellite instability and mutation of DNA mismatch repair genes in gliomas.

Authors:  S Y Leung; T L Chan; L P Chung; A S Chan; Y W Fan; K N Hung; W K Kwong; J W Ho; S T Yuen
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.